SLLN-15
SLLN-15 is an oral active, selective and potent enhancer of autophagy that activates cytostatic macroautophagy/autophagy in triple-negative breast cancer (TNBC) [1].
Product Specifications
CAS Number
[2403650-93-9]
UNSPSC
12352005
Target
Autophagy
Type
Reference compound
Related Pathways
Autophagy
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SLLN-15.html
Solubility
10 mM in DMSO
Smiles
C12=NC(NC3=CC=C(N4CC[Se]CC4)C=C3)=NC(N[C@@H]5C[Se]CC5)=C1N=CN2
Molecular Formula
C19H23N7Se2
Molecular Weight
507.35
References & Citations
[1]Chang CH, et al. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Autophagy. 2019 Mar 1:1-15.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC222641L4 10 µg
C3orf70 (NM_001025266) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
K2062802 1.0 µg DNA
RPS29P28 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
135818-ML650 100 µL
ZNHIT3 (Zinc Finger HIT Domain-containing Protein 3, HNF-4a Coactivator, Thyroid Hormone Receptor Interactor 3, Thyroid Receptor-interacting Protein 3, TR-interacting Protein 3, TRIP3, TRIP-3) (MaxLight 650)
Sign In for Pricing
View Details 